{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:54:38Z","timestamp":1761630878583},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/bf03404324","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T20:53:22Z","timestamp":1568321602000},"page":"130-133","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and Associated Factors of Hepatitis C Infection (HCV) in a Multi-site Canadian Population of Illicit Opioid and Other Drug Users (OPICAN)"],"prefix":"10.17269","volume":"98","author":[{"given":"Michelle","family":"Firestone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayadeep","family":"Patra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Kalousek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Newton-Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"BF03404324_CR1","first-page":"91","volume-title":"EMCDDA Monographs: Hepatitis C and Injection Drug Use: Impact, Costs and Policy Options","author":"L Wiessing","year":"2004","unstructured":"Wiessing L, Roy K, Sapinho D, Hay G, Taylor A, Goldberg D et al. Surveillance of hepatitis C infection among injecting drug users in the European Union. In: Jager J, Limburg W, Kretzschmar M, Postma M, Weissing L (Eds.), EMCDDA Monographs: Hepatitis C and Injection Drug Use: Impact, Costs and Policy Options. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction, 2004;91\u2013135."},{"key":"BF03404324_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jurban\/jth128","volume":"81","author":"B Fischer","year":"2004","unstructured":"Fischer B, Haydon E, Rehm J, Krajden M, Reimer J. Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach-The case study of Canada. J Urban Health 2004;81:428\u201347.","journal-title":"J Urban Health"},{"key":"BF03404324_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41\u201352.","journal-title":"N Engl J Med"},{"issue":"Suppl.1","key":"BF03404324_CR4","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/BF03405100","volume":"91","author":"S Zou","year":"2000","unstructured":"Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl. 1):S10\u2013S15.","journal-title":"Can J Public Health"},{"issue":"2","key":"BF03404324_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF03404585","volume":"94","author":"S Zou","year":"2003","unstructured":"Zou S, Forrester L, Giulivi A. Hepatitis C update. Can J Public Health 2003;94(2):127\u201329.","journal-title":"Can J Public Health"},{"key":"BF03404324_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1469-0691.2004.00934.x","volume":"10","author":"J Harder","year":"2004","unstructured":"Harder J, Walter E, Riecken B, Ihling C, Bauer TM. Hepatitis C virus infection in intravenous drug users. Clin Microbiol Infect 2004;10:768\u201370.","journal-title":"Clin Microbiol Infect"},{"key":"BF03404324_CR7","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1086\/427440","volume":"40","author":"M Sulkowski","year":"2005","unstructured":"Sulkowski M, Thomas D. Epidemiology and natural history of Hepatitis C virus infection in injection drug users: Implications for treatment. Clin Infect Dis 2005;40:S263\u2013S269.","journal-title":"Clin Infect Dis"},{"key":"BF03404324_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/aje\/155.7.645","volume":"155","author":"LE Thorpe","year":"2002","unstructured":"Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002;155:645\u201353.","journal-title":"Am J Epidemiol"},{"issue":"Suppl5","key":"BF03404324_CR9","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1086\/427441","volume":"40","author":"BR Edlin","year":"2005","unstructured":"Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005;40(Suppl 5):S276\u2013S285.","journal-title":"Clin Infect Dis"},{"key":"BF03404324_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2105\/AJPH.91.9.1350","volume":"91","author":"H Hagan","year":"2001","unstructured":"Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42\u201346.","journal-title":"Am J Public Health"},{"key":"BF03404324_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2105\/AJPH.91.1.23","volume":"91","author":"T Diaz","year":"2001","unstructured":"Diaz T, Des Jarlais D, Vlahov D, Perlis TE, Edwards V, Friedman SR et al. Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001;91:23\u201330.","journal-title":"Am J Public Health"},{"key":"BF03404324_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1024603517136","volume":"18","author":"M Backmund","year":"2003","unstructured":"Backmund M, Meyer K, Wachtler M, Eichenlaub D. Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity. Eur J Epidemiol 2003;18:563\u201368.","journal-title":"Eur J Epidemiol"},{"key":"BF03404324_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","volume":"86","author":"RS Garfein","year":"1996","unstructured":"Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655\u201361.","journal-title":"Am J Public Health"},{"key":"BF03404324_CR14","first-page":"889","volume":"165","author":"DM Patrick","year":"2001","unstructured":"Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 2001;165:889\u201395.","journal-title":"CMAJ"},{"key":"BF03404324_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00042560-199802010-00010","volume":"17","author":"CP Archibald","year":"1998","unstructured":"Archibald CP, Ofner M, Strathdee SA, Patrick DM, Sutherland D, Rekart ML et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:160\u201366.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"BF03404324_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1081\/JA-120028488","volume":"39","author":"S Tortu","year":"2004","unstructured":"Tortu S, McMahon J, Pouget E, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004;39:211\u201324.","journal-title":"Subst Use Misuse"},{"key":"BF03404324_CR17","first-page":"557","volume":"165","author":"E Roy","year":"2001","unstructured":"Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001;165:557\u201360.","journal-title":"CMAJ"},{"key":"BF03404324_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jama.1993.03500030090039","volume":"269","author":"HS Weinstock","year":"1993","unstructured":"Weinstock HS, Bolan G, Reingold AL, Polish LB. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993;269:392\u201394.","journal-title":"JAMA"},{"key":"BF03404324_CR19","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1086\/313842","volume":"30","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30:S77\u2013S84.","journal-title":"Clin Infect Dis"},{"key":"BF03404324_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.drugalcdep.2004.02.002","volume":"75","author":"JA Stein","year":"2004","unstructured":"Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: A latent variable approach. Drug Alcohol Depend 2004;75:89\u201395.","journal-title":"Drug Alcohol Depend"},{"key":"BF03404324_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00004836-200204000-00021","volume":"34","author":"RC Cheung","year":"2002","unstructured":"Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol 2002;34:476\u201380.","journal-title":"J Clin Gastroenterol"},{"key":"BF03404324_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/430913","volume":"41","author":"RK Fox","year":"2005","unstructured":"Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005;41:177\u201386.","journal-title":"Clin Infect Dis"},{"key":"BF03404324_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1590\/S1413-86702001000300002","volume":"5","author":"T Guimaraes","year":"2001","unstructured":"Guimaraes T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallas EG. High prevalence of hepatitis C infection in a Brazilian prison: Identification of risk factors for infection. Braz J Infect Dis 2001;5:111\u201318.","journal-title":"Braz J Infect Dis"},{"key":"BF03404324_CR24","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1086\/345554","volume":"186","author":"JA Hahn","year":"2002","unstructured":"Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J Infect Dis 2002;186:1558\u201364.","journal-title":"J Infect Dis"},{"key":"BF03404324_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1467-842X.2004.tb00050.x","volume":"28","author":"R Hallinan","year":"2004","unstructured":"Hallinan R, Byrne A, Amin J, Dore GJ. Hepatitis C virus incidence among injecting drug users on opioid replacement therapy. Aust N Z J Public Health 2004;28:576\u201378.","journal-title":"Aust N Z J Public Health"},{"key":"BF03404324_CR26","volume-title":"Final Statement","author":"National Institutes of Health.","year":"2002","unstructured":"National Institutes of Health. Management of hepatitis C: 2002. Final Statement. Washington, National Institutes of Health, 2002."},{"key":"BF03404324_CR27","first-page":"345","volume-title":"EMCDDA Monographs: Hepatitis C and injecting drug use: impact, costs and policy options","author":"H Pollack","year":"2004","unstructured":"Pollack H, Heimer R. The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and Hepatitis C. In: Jager J, Limburg W, Kretzschmar M, Postma M, Weissing L (Eds.), EMCDDA Monographs: Hepatitis C and injecting drug use: impact, costs and policy options. Luxembourg: EMCDDA, 2004;345\u201367."},{"key":"BF03404324_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jurban\/jti049","volume":"82","author":"B Fischer","year":"2005","unstructured":"Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, el-Guebaly N et al. Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 2005;82:250\u201366.","journal-title":"J Urban Health"},{"key":"BF03404324_CR29","unstructured":"SPSS for Windows [Version] 12, 2005."},{"key":"BF03404324_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3109\/10826089809062214","volume":"33","author":"H Hagan","year":"1998","unstructured":"Hagan H. Hepatitis C virus transmission dynamics in injection drug users. Subst Use Misuse 1998;33:1197\u2013212.","journal-title":"Subst Use Misuse"},{"key":"BF03404324_CR31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","volume":"18","author":"R Garfein","year":"1998","unstructured":"Garfein R, Doherty MC, Monterroso ER, Thomas DL, Nelson K, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:S11\u2013S19.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"BF03404324_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/01459740.2000.9966161","volume":"18","author":"P Bourgois","year":"2000","unstructured":"Bourgois P, Bruneau J. Needle exchange, HIV infection, and the politics of science: Confronting Canada\u2019s cocaine injection epidemic with participant observation. Med Anthropol 2000;18:325\u201350.","journal-title":"Med Anthropol"},{"key":"BF03404324_CR33","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2105\/AJPH.83.8.1144","volume":"83","author":"R Booth","year":"1993","unstructured":"Booth R, Watters J, Chitwood D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 1993;83:1144\u201348.","journal-title":"Am J Public Health"},{"key":"BF03404324_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jurban\/jth129","volume":"81","author":"J Gates","year":"2004","unstructured":"Gates J, Post J, Kaldor J, Pan Y, Haber P, Lloyd A et al. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia. J Urban Health 2004;81:448\u201352.","journal-title":"J Urban Health"},{"issue":"Suppl5","key":"BF03404324_CR35","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.1086\/427447","volume":"40","author":"DL Sylvestre","year":"2005","unstructured":"Sylvestre DL. Treating hepatitis C virus infection in active substance users. Clin Infect Dis 2005;40(Suppl 5):S321\u2013S324.","journal-title":"Clin Infect Dis"},{"issue":"Suppl5","key":"BF03404324_CR36","doi-asserted-by":"publisher","first-page":"S330","DOI":"10.1086\/427475","volume":"40","author":"M Backmund","year":"2005","unstructured":"Backmund M, Reimer J, Meyer K, Gerlach JT, Reinhart Z. Hepatitis C virus infection and injection drug users: Prevention, risk factors, and treatment. Clin Infect Dis 2005;40(Suppl 5):S330\u2013S335.","journal-title":"Clin Infect Dis"},{"key":"BF03404324_CR37","doi-asserted-by":"publisher","first-page":"S259","DOI":"10.1086\/427438","volume":"40","author":"T Kresina","year":"2005","unstructured":"Kresina T, Khalsa J, Cesari H, Francis H. Hepatitis C virus infection and substance abuse: Medical management and developing models of integrated care-An introduction. Clin Infect Dis 2005;40:S259\u2013S262.","journal-title":"Clin Infect Dis"},{"key":"BF03404324_CR38","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","volume":"359","author":"S Mehta","year":"2002","unstructured":"Mehta S, Cox A, Hoover D, Wang X-H, Mao Q, Ray S et al. Protection against persistence of hepatitis C. Lancet 2002;359:1478\u201383.","journal-title":"Lancet"},{"key":"BF03404324_CR39","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1053\/jhep.2001.27831","volume":"34","author":"AJ Freeman","year":"2001","unstructured":"Freeman AJ, Dore GJ, Law MG, Thorpe M, Von OJ, Lloyd AR et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809\u201316.","journal-title":"Hepatology"},{"key":"BF03404324_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: A review. Drug Alcohol Depend 1998;51:253\u201362.","journal-title":"Drug Alcohol Depend"},{"key":"BF03404324_CR41","volume-title":"Applied Logistic Regression","author":"D Hosmer","year":"1989","unstructured":"Hosmer D, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons, 1989."},{"key":"BF03404324_CR42","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1086\/317607","volume":"182","author":"LE Thorpe","year":"2000","unstructured":"Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997\u20131999. J Infect Dis 2000;182:1588\u201394.","journal-title":"J Infect Dis"},{"issue":"6","key":"BF03404324_CR43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF03405233","volume":"97","author":"B Fischer","year":"2006","unstructured":"Fischer B, Kalousek K, Rehm J, Powis J, Krajden M, Reimer J. Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan? Can J Public Health 2006;97(6):485\u201388.","journal-title":"Can J Public Health"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03404324\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03404324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T16:44:57Z","timestamp":1568393097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03404324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF03404324"],"URL":"https:\/\/doi.org\/10.1007\/bf03404324","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}